The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328
Genetic associations with human longevity at the APOE and ACE loci
Schächter, F., Faure-Delanef, L., Guénot, F., Rouger, H., Froguel, P., Lesueur-Ginot, L., & Cohen, D. (1994) · Nature Genetics · doi:10.1038/ng0194-29 · Cited by 1,095
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis
Bäckman, L., Jones, S., Berger, A.-K., Laukka, E. J., & Small, B. J. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.4.520 · Cited by 735
O'Brien, J. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2081 · Cited by 409
Harris, F. M., Brecht, W. J., Xu, Q., Tesseur, I., Kekonius, L., Wyss-Coray, T., Fish, J. D., Masliah, E., Hopkins, P. C., Scearce-Levie, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1434398100 · Cited by 342
Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thal, L. J. (1999) · Psychology and Aging · doi:10.1037//0882-7974.14.2.295 · Cited by 235
Research works printed but not linked: 95
- *Alexander, 2007, The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades, Biol. Psychol., 75, 229, 10.1016/j.biopsycho.2007.03.001 · DOI
- *Askar, 2005, Apolipoprotein E epsilon4 allele and neurobehavioral status after on-pump coronary artery bypass grafting, J. Card. Surg., 20, 501, 10.1111/j.1540-8191.2005.2004138.x · DOI
- Bachman, 1992, Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study, Neurology, 42, 115, 10.1212/WNL.42.1.115 · DOI · Paper page
- *Bartzokis, 2006, Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia, Arch. Gen. Psychiatry, 63, 63, 10.1001/archpsyc.63.1.63 · DOI
- *Bathum, 2006, Apolipoprotein e genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians, J. Am. Geriatr. Soc., 54, 654, 10.1111/j.1532-5415.2005.53554.x · DOI
- *Berr, 1996, Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study, Neurosci. Lett., 218, 9, 10.1016/0304-3940(96)13059-7 · DOI
- *Blair, 2005, APOE genotype and cognitive decline in a middle-aged cohort, Neurology, 64, 268, 10.1212/01.WNL.0000149643.91367.8A · DOI · Paper page
- Bretsky, 2003, The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur studies of successful aging, Neurology, 60, 1077, 10.1212/01.WNL.0000055875.26908.24 · DOI · Paper page
- *Bunce, 2005, Apolipoprotein E, B vitamins, and cognitive function in older adults, J. Gerontol. B Psychol. Sci. Soc. Sci., 60, 41, 10.1093/geronb/60.1.P41 · DOI
- *Burkhardt, 2004, Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4, J. Alzheimers Dis., 6, 221, 10.3233/JAD-2004-6302 · DOI
- Cacabelos, 2003, The application of functional genomics to Alzheimer's disease, Pharmacogenomics, 4, 597, 10.1517/phgs.4.5.597.23795 · DOI
- *Calhoun-Haney, 2005, Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores, Brain Cogn., 58, 178, 10.1016/j.bandc.2004.10.004 · DOI
- *Caselli, 2002, A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE ɛ4 homozygotes, Sleep, 25, 447
- Corder, 1996, Attenuation of apolipoprotein E epsilon 4 allele gene dose in late age, Lancet, 347, 542, 10.1016/S0140-6736(96)91173-3 · DOI
- Corder, 2008, Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci, Rejuvenat. Res., 11, 667, 10.1089/rej.2008.0742 · DOI
- Corder, 2008, Alzheimer pathogenesis for men and women, Alzheimer Dis. Res. J., 2, 39
- Corder, 1996, Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition, Arch. Neurol., 53, 418, 10.1001/archneur.1996.00550050048022 · DOI
- Corder, 1995, Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease, Neurology, 45, 1323, 10.1212/WNL.45.7.1323 · DOI · Paper page
- *Deary, 2002, Cognitive change and the APOE epsilon 4 allele, Nature, 418, 932, 10.1038/418932a · DOI · Paper page
- *Deeny, 2008, Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in epsilon4 carriers, Biol. Psychol., 78, 179, 10.1016/j.biopsycho.2008.02.007 · DOI · Paper page
- *den Heijer, 2002, Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes, Neurology, 59, 746, 10.1212/WNL.59.5.746 · DOI · Paper page
- *Dik, 2000, APOE-epsilon4 is associated with memory decline in cognitively impaired elderly, Neurology, 54, 1492, 10.1212/WNL.54.7.1492 · DOI
- *Driscoll, 2005, Apolipoprotein E and prospective memory in normally aging adults, Neuropsychology, 19, 28, 10.1037/0894-4105.19.1.28 · DOI
- *Espeseth, 2008, Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4, Neurobiol. Aging, 29, 329, 10.1016/j.neurobiolaging.2006.10.030 · DOI
- Evans, 1990, Estimated prevalence of Alzheimer's disease in the United States, Milbank Q, 68, 267, 10.2307/3350099 · DOI · Paper page
- *Flicker, 2004, Homocysteine, Alzheimer genes and proteins, and measures of cognition and depression in older men, J. Alzheimers Dis., 6, 329, 10.3233/JAD-2004-6313 · DOI
- *Flory, 2000, Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults, Am. J. Med. Genet., 96, 707, 10.1002/1096-8628(20001204)96:6<707::AID-AJMG1>3.0.CO;2-V · DOI
- *Frisoni, 2005, Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study, J. Neurol. Neurosurg. Psychiatry, 76, 112, 10.1136/jnnp.2003.029876 · DOI · Paper page
- *Gilbert, 2004, The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls, J. Clin. Exp. Neuropsychol., 26, 779, 10.1080/13803390490509439 · DOI
- Hall, 1991, Testing for moderating variables in meta-analysis: Issues and methods, Commun. Monogr., 58, 437, 10.1080/03637759109376240 · DOI
- Hawkins, 1996, Limitations of cognitive status exams: a case-based discussion, Psychiatry, 59, 382, 10.1080/00332747.1996.11024777 · doi:10.1080/00332747.1996.11024777
- *Helkala, 1995, The association of apolipoprotein E polymorphism with memory: a population based study, Neurosci. Lett., 191, 141, 10.1016/0304-3940(95)11575-H · DOI
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Hirono, 2003, Accelerated memory decline in Alzheimer's disease with Apolipoprotein epsilon 4 allele, J. Neuropsychiatry Clin. Neurosci., 15, 354, 10.1176/appi.neuropsych.15.3.354 · DOI
- *Hofer, 2002, Change in cognitive functioning associated with apoE genotype in a community sample of older adults, Psychol. Aging, 17, 194, 10.1037/0882-7974.17.2.194 · DOI
- *Houston, 2005, Executive function asymmetry in older adults genetically at-risk for Alzheimer's disease: verbal versus design fluency, J. Int. Neuropsychol. Soc., 11, 863, 10.1017/S1355617705051015 · DOI
- *Hu, 2006, Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging, J. Gerontol. A Biol. Sci. Med. Sci., 61, 616, 10.1093/gerona/61.6.616 · DOI
- *Hwang, 2006, Association of APOE genetic polymorphism with cognitive function and suicide history in geriatric depression, Dement. Geriatr. Cogn. Disord., 22, 334, 10.1159/000095599 · DOI
- *Irie, 2008, Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study, Arch. Neurol., 65, 89, 10.1001/archneurol.2007.29 · DOI · Paper page
- *Jessen, 2007, Patterns of subjective memory impairment in the elderly: association with memory performance, Psychol. Med., 37, 1753, 10.1017/S0033291707001122 · DOI · Paper page
- Johnson, 1995, Comparison of three major meta-analytic approaches, Journal of, Appl. Psychol., 80, 94, 10.1037/0021-9010.80.1.94 · DOI
- *Johnson, 2006, The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation, J. Neurosci., 26, 6069, 10.1523/JNEUROSCI.0959-06.2006 · DOI
- *Jorm, 2007, APOE genotype and cognitive functioning in a large age-stratified population sample, Neuropsychology, 21, 1, 10.1037/0894-4105.21.1.1 · DOI
- *Juva, 2000, Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over, Int. Psychogeriatr., 12, 379, 10.1017/S1041610200006487 · DOI
- Kamboh, 2006, Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures, Mol. Psychiatry, 11, 273, 10.1038/sj.mp.4001775 · DOI
- *Kim, 2002, Apolipoprotein E epsilon 4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals, Int. J. Geriatr. Psychiatry, 17, 635, 10.1002/gps.664 · DOI
- *Klages, 2003, APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging, Dement. Geriatr. Cogn. Disord., 15, 1, 10.1159/000066670 · DOI
- *Kryscio, 2006, Risk factors for transitions from normal to mild cognitive impairment and dementia, Neurology, 66, 828, 10.1212/01.wnl.0000203264.71880.45 · DOI · Paper page
- Lahiri, 2004, Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease, Neurobiol. Aging, 25, 651, 10.1016/j.neurobiolaging.2003.12.024 · DOI
- *Lehmann, 2006, Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study, J. Neurol. Neurosurg. Psychiatry, 77, 902, 10.1136/jnnp.2005.077818 · DOI
- *Levy, 2004, Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease, J. Int. Neuropsychol. Soc., 10, 362, 10.1017/S1355617704103044 · DOI
- Licastro, 2007, Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation, Neurobiol. Aging, 28, 1637, 10.1016/j.neurobiolaging.2006.07.007 · DOI
- Marra, 2004, Apolipoprotein E epsilon 4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients, Dement. Geriatr. Cogn. Disord., 18, 125, 10.1159/000079191 · DOI
- Martins, 2005, APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model, Neurology, 65, 1888, 10.1212/01.wnl.0000188871.74093.12 · DOI · Paper page
- *Moffat, 2000, Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype, Neurology, 55, 134, 10.1212/WNL.55.1.134 · DOI · Paper page
- *Mondadori, 2007, Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers, Cereb. Cortex, 17, 1934, 10.1093/cercor/bhl103 · DOI · Paper page
- *Moore, 2005, Eyeblink classical conditioning to auditory and olfactory stimuli: performance among older adults with and without the apolipoprotein E epsilon 4 allele, Neuropsychology, 19, 437, 10.1037/0894-4105.19.4.437 · DOI
- *Mosconi, 2008, Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints, Biol. Psychiatry, 63, 609, 10.1016/j.biopsych.2007.05.030 · DOI · Paper page
- *Newman, 2000, Talkativeness in cognitively normal women at genetic risk for Alzheimer's disease, Aging Neuropsychol. Cogn., 7, 217, 10.1076/anec.7.4.217.797 · DOI
- *Nilsson, 2006, The influence of APOE status on episodic and semantic memory: data from a population-based study, Neuropsychology, 20, 645, 10.1037/0894-4105.20.6.645 · DOI
- *O’Hara, 1998, The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults, J. Am. Geriatr. Soc., 46, 1493, 10.1111/j.1532-5415.1998.tb01532.x · DOI
- Parker, 2005, Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease, Psychiatr. Genet., 15, 271, 10.1097/00041444-200512000-00009 · DOI
- *Payton, 2006, Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population, Genes Brain Behav., 5, 23, 10.1111/j.1601-183X.2006.00191.x · DOI
- *Peavy, 2007, The effects of prolonged stress and APOE genotype on memory and cortisol in older adults, Biol. Psychiatry, 62, 472, 10.1016/j.biopsych.2007.03.013 · DOI
- *Persson, 2006, Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?, Neurology, 66, 1029, 10.1212/01.wnl.0000204180.25361.48 · DOI · Paper page
- Plassman, 1996, Apolipoprotein E and cognitive decline in Alzheimer's disease, Neurology, 47, 317, 10.1212/WNL.47.2.317 · DOI
- *Plassman, 1997, Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition, Neurology, 48, 985, 10.1212/WNL.48.4.985 · DOI
- *Pomara, 2005, Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults, Arch. Gen. Psychiatry, 62, 209, 10.1001/archpsyc.62.2.209 · DOI
- *Reynolds, 2006, Longitudinal memory performance during normal aging: twin association models of APOE and other Alzheimer candidate genes, Behav. Genet., 36, 185, 10.1007/s10519-005-9027-6 · DOI
- *Riley, 2000, Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study, J. Gerontol. B Psychol. Sci. Soc. Sci., 55, S69, 10.1093/geronb/55.2.S69 · DOI
- *Robson, 2002, Apolipoprotein E and neurocognitive outcome from coronary artery surgery, J. Neurol. Neurosurg. Psychiatry, 72, 675, 10.1136/jnnp.72.5.675 · DOI
- Rocchi, 2003, Causative and susceptibility genes for Alzheimer's disease: a review, Brain Res. Bull., 61, 1, 10.1016/S0361-9230(03)00067-4 · DOI · Paper page
- *Rosen, 2002, Working memory and apolipoprotein E: what's the connection?, Neuropsychologia, 40, 2226, 10.1016/S0028-3932(02)00132-X · DOI
- *Sager, 2005, Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention, J. Geriatr. Psychiatry Neurol., 18, 245, 10.1177/0891988705281882 · DOI · Paper page
- *Salo, 2001, Does apolipoprotein E influence learning and memory in the nondemented oldest old?, Int. Psychogeriatr., 13, 451, 10.1017/S1041610201007864 · DOI
- *Savitz, 2007, Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants, Biol. Psychiatry, 62, 391, 10.1016/j.biopsych.2006.10.017 · DOI
- *Schmidt, 1996, Apolipoprotein E ɛ4 allele in the normal elderly: neuropsychologic and brain MRI correlates, Clin. Genet., 50, 293, 10.1111/j.1399-0004.1996.tb02377.x · DOI
- *Small, 1998, Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia, Psychol. Aging, 13, 80, 10.1037/0882-7974.13.1.80 · doi:10.1037/0882-7974.13.1.80
- *Small, 2000, Is APOE—epsilon4 a risk factor for cognitive impairment in normal aging?, Neurology, 54, 2082, 10.1212/WNL.54.11.2082 · DOI
- Small, 2004, Apolipoprotein E and cognitive performance: a meta-analysis, Psychol. Aging, 19, 592, 10.1037/0882-7974.19.4.592 · DOI · Paper page
- *Smith, 1998, Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects, Neurology, 50, 355, 10.1212/WNL.50.2.355 · DOI · Paper page
- *Steed, 2001, The role of apolipoprotein E in cognitive decline after cardiac operation, Ann. Thorac. Surg., 71, 823, 10.1016/S0003-4975(00)02511-X · DOI
- *Sun, 2007, Decreased cerebral blood flow velocity in apolipoprotein E epsilon4 allele carriers with mild cognitive impairment, Eur. J. Neurol., 14, 150, 10.1111/j.1468-1331.2006.01579.x · DOI
- *Swan, 2005, Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults, J. Geriatr. Psychiatry Neurol., 18, 196, 10.1177/0891988705281864 · DOI
- *Tagarakis, 2007, The role of apolipoprotein E in cognitive decline and delirium after bypass heart operations, Am. J. Alzheimers Dis. Other Demen., 22, 223, 10.1177/1533317507299415 · DOI
- *Tardiff, 1997, Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center, Ann. Thorac. Surg., 64, 715, 10.1016/S0003-4975(97)00757-1 · DOI · Paper page
- *Tohgi, 1997, Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele, Neurosci. Lett., 236, 21, 10.1016/S0304-3940(97)00743-X · DOI
- *Tupler, 2007, Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve, Neurobiol. Aging, 28, 1644, 10.1016/j.neurobiolaging.2006.07.001 · DOI
- van der Cammen, 2004, Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease, J. Am. Geriatr. Soc., 52, 2110, 10.1111/j.1532-5415.2004.52573.x · DOI
- *Wang, 2006, Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan, Neurobiol. Aging, 27, 1797, 10.1016/j.neurobiolaging.2005.10.002 · DOI
- *Wilson, 2002, The apolipoprotein E epsilon 2 allele and decline in episodic memory, J. Neurol. Neurosurg. Psychiatry, 73, 672, 10.1136/jnnp.73.6.672 · DOI · Paper page
- *Wilson, 2002, The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period, Arch. Neurol., 59, 1154, 10.1001/archneur.59.7.1154 · DOI · Paper page
- *Wishart, 2006, Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele, Am. J. Psychiatry, 163, 1603, 10.1176/appi.ajp.163.9.1603 · doi:10.1176/appi.ajp.163.9.1603
- *Yaffe, 1997, Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women, Arch. Neurol., 54, 1110, 10.1001/archneur.1997.00550210044011 · DOI
- Yip, 2002, Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population, J. Med. Genet., 39, 639, 10.1136/jmg.39.9.639 · DOI
Cited by
Power failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641
Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00363 · Cited by 1,416
The neuroscience of human intelligence differences
Deary, I. J., Penke, L., & Johnson, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2793 · Cited by 1,038
Genome-wide association studies establish that human intelligence is highly heritable and polygenic
Davies, G., Tenesa, A., Payton, A., Yang, J., Harris, S. E., Liewald, D., Ke, X., Le Hellard, S., Christoforou, A., Luciano, M., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.85 · Cited by 608
Deary, I. J. (2012) · Annual Review of Psychology · doi:10.1146/annurev-psych-120710-100353 · Cited by 467
Metadata
- Authors
- Wisdom, N. M., Callahan, J. L., & Hawkins, K. A.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 32
- Issue
- 1
- Pages
- 63-74
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2009339691
- Cited by
- 415
- References
- 14
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2009.02.003
- The paper
- Wisdom, N. M., Callahan, J. L., & Hawkins, K. A. (2011). The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2009.02.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.